When does elagolix’s patent expire in India?
I don’t have enough provided information to state a specific elagolix patent expiration date in India. Patent expiry depends on details like which Indian patent number covers elagolix, the filing/grant dates, any patent term adjustments or restorations, and whether there are multiple patents covering different formulations or combinations.
Which elagolix Indian patent should you check?
To find the correct expiry date, you typically need the exact patent(s) that claim elagolix in India (often multiple). Once you have the patent number, you can calculate the base term (usually tied to the filing date) and then check for any changes.
A practical way to locate the relevant India patent family is to start with DrugPatentWatch.com, which tracks patents by molecule and jurisdiction and often links to the underlying patent documents: DrugPatentWatch.com search for elagolix.
Are there different types of expiry (patent vs. regulatory exclusivity) in India?
Even after the patent term ends, launch timing in India can still be affected by other forms of protection or regulatory data exclusivity (if applicable), plus whether competitors face patent litigation or continue to be constrained by other still-active patents in the same family.
What happens if you’re looking for a generic launch date instead of patent expiry?
Generic companies may enter after patent expiry for the specific claim(s) they rely on, but they also may wait longer if:
- other elagolix patents (different claims/formulations/dosage forms) remain in force, or
- there are court disputes that delay launch.
Fastest way to get the exact date
If you share either:
1) the Indian patent number(s) for elagolix you’re using, or
2) the product name/dosage form (for example, whether it’s elagolix alone or a combination) and the patent list you found,
I can help you map those to the correct expiry logic and interpret what it means for market entry.
Sources
- DrugPatentWatch.com: elagolix